Precigen (PGEN) News Today → Elon to Transform U.S. Economy? (From Porter & Company) (Ad) Free PGEN Stock Alerts $1.27 -0.02 (-1.55%) (As of 05/10/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlinePrecigen (PGEN) Scheduled to Post Earnings on Tuesdaymarketbeat.com - May 9 at 9:02 AMPrecigen to Announce First Quarter 2024 Financial Results on May 14th and Host a Conference Call on June 3rd following the Late-breaking Oral Presentation for PRGN-2012 at the 2024 ASCO Annual Meetingprnewswire.com - May 8 at 4:05 PMActym Therapeutics Inc.: Actym Therapeutics Appoints Thomas Smart as CEOfinanznachrichten.de - April 26 at 1:53 AMPrecigen to Present Late-breaking Abstract for Pivotal Phase 2 Study Data for PRGN-2012 AdenoVerse Immunotherapy for the Treatment of Patients with Recurrent Respiratory Papillomatosis at the 2024 ASCO Annual Meetingprnewswire.com - April 24 at 10:20 AMActym Therapeutics Appoints Thomas Smart as CEOprnewswire.com - April 24 at 9:00 AMPrecigen and Recurrent Respiratory Papillomatosis Foundation to Hold Inaugural International RRP Awareness Day on June 11thprnewswire.com - March 28 at 4:05 PMAnalysts Offer Insights on Healthcare Companies: Precigen (PGEN), Cronos Group (CRON) and Marinus (MRNS)markets.businessinsider.com - March 26 at 7:58 PMJ.P. Morgan cuts Precigen to underweight, cites burn ratemsn.com - March 22 at 6:03 PMPrecigen (NASDAQ:PGEN) Downgraded by JPMorgan Chase & Co. to Underweightmarketbeat.com - March 22 at 8:17 AMPrecigen, Inc. (NASDAQ:PGEN) to Post Q1 2024 Earnings of ($0.09) Per Share, HC Wainwright Forecastsmarketbeat.com - March 22 at 7:34 AMGermantown biotech expands manufacturing capacity, headcount ahead of potential product launchbizjournals.com - March 21 at 6:00 PMBuy Rating Affirmed on Precigen Amid Promising PRGN-2012 Clinical Progress and Financial Stabilitymarkets.businessinsider.com - March 20 at 5:19 PMPrecigen, Inc. (NASDAQ:PGEN) Q4 2023 Earnings Call Transcriptfinance.yahoo.com - March 20 at 4:34 PMPrecigen's (PGEN) "Market Outperform" Rating Reaffirmed at JMP Securitiesmarketbeat.com - March 20 at 10:39 AMAnalysts Offer Insights on Healthcare Companies: Precigen (PGEN) and Taysha Gene Therapies (TSHA)markets.businessinsider.com - March 20 at 5:18 AMPrecigen, Inc. (PGEN) Q4 2023 Earnings Call Transcriptseekingalpha.com - March 19 at 10:05 PMPGEN Stock Earnings: Precigen Misses EPS, Misses Revenue for Q4 2023investorplace.com - March 19 at 10:01 PMPrecigen Inc (PGEN) Reports Full Year 2023 Financial Resultsfinance.yahoo.com - March 19 at 5:55 PMRecap: Precigen Q4 Earningsbenzinga.com - March 19 at 5:22 PMPrecigen Reports Full Year 2023 Financial Results and Business Updatesfinance.yahoo.com - March 19 at 5:05 PMUS Index Futures Decline Ahead of Federal Reserve Meeting, Oil Prices Retreatmsn.com - March 19 at 7:54 AMPreview: Precigen's Earningsbenzinga.com - March 18 at 11:01 AMAnika Therapeutics to reduce workforce by 9%msn.com - March 14 at 4:42 AMPrecigen to Participate in a Fireside Chat Hosted by Cantor Fitzgerald to Discuss PRGN-2012 AdenoVerse Immunotherapy for the Treatment of Recurrent Respiratory Papillomatosisfinance.yahoo.com - March 12 at 5:56 PMPrecigen, Inc.'s (NASDAQ:PGEN) top owners are private equity firms with 38% stake, while 30% is held by institutionsfinance.yahoo.com - March 8 at 7:39 AMPrecigen to Announce Fourth Quarter and Full Year 2023 Financial Results on March 19thprnewswire.com - March 5 at 4:05 PMPrecigen, Inc. (NASDAQ:PGEN): When Will It Breakeven?finance.yahoo.com - February 20 at 2:57 PMPGEN Mar 2024 1.500 callfinance.yahoo.com - February 15 at 7:32 PMPGEN Jul 2024 1.500 callfinance.yahoo.com - February 15 at 2:31 PMPGEN Jul 2024 2.500 putfinance.yahoo.com - February 15 at 9:31 AMPGEN Jul 2024 0.500 callfinance.yahoo.com - February 15 at 9:31 AMPrecigen Finalizes Executive Severance Agreementsmsn.com - February 9 at 8:53 AMPrecigen to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conferencefinance.yahoo.com - February 6 at 5:45 PMInsider Stock Buying Reaches US$1.72m On Precigenfinance.yahoo.com - February 4 at 10:04 AMWe're Keeping An Eye On Precigen's (NASDAQ:PGEN) Cash Burn Ratefinance.yahoo.com - January 18 at 8:19 AMPrecigen gets EU orphan drug status for respiratory tract drugmsn.com - January 16 at 12:18 PMPrecigen Receives Orphan Drug Designation for PRGN-2012 for the Treatment of Recurrent Respiratory Papillomatosis from the European Commissionfinance.yahoo.com - January 16 at 8:33 AMIridian Asset Management LLC CT Trims Holdings in Precigen, Inc. (NASDAQ:PGEN)marketbeat.com - January 12 at 1:58 PMBuy Rating on Precigen: Anticipated BLA Submission and Diverse Pipeline Drive Positive Outlookmarkets.businessinsider.com - January 10 at 8:45 AMPrecigen Highlights Pipeline Updates to be Presented at the 42nd Annual J.P. Morgan Healthcare Conferencefinance.yahoo.com - January 8 at 8:58 AMTuesday 1/2 Insider Buying Report: PGEN, TURNnasdaq.com - January 4 at 6:23 PMDirector Jeffrey Kindler Sells 96,686 Shares of Precigen Incuk.finance.yahoo.com - December 31 at 7:13 AMPrecigen, Inc. (NASDAQ:PGEN) Director Randal J. Kirk Acquires 96,686 Sharesmarketbeat.com - December 29 at 9:28 PMPrecigen files for $300M mixed shelfmsn.com - December 29 at 7:58 PMEven after rising 15% this past week, Precigen (NASDAQ:PGEN) shareholders are still down 86% over the past three yearsfinance.yahoo.com - December 27 at 9:37 AMPrecigen to Present at the 42nd Annual J.P. Morgan Healthcare Conferencefinance.yahoo.com - December 18 at 6:55 PMPrecigen to Participate in the JMP Securities Hematology and Oncology Summitfinance.yahoo.com - November 29 at 4:56 PMPrecigen Inc PGENmorningstar.com - November 22 at 8:18 PMPromising Pipeline Progress and Strong Financial Standing Justify Buy Rating for Precigenmarkets.businessinsider.com - November 11 at 7:52 PMAnalysts Offer Insights on Healthcare Companies: Intellia Therapeutics (NTLA) and Precigen (PGEN)markets.businessinsider.com - November 10 at 1:35 PM Get Precigen News Delivered to You Automatically Sign up to receive the latest news and ratings for PGEN and its competitors with MarketBeat's FREE daily newsletter. Email Address Claim Your Complimentary Bitcoin Reward (Ad)Many have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached. Secure Your Spot Now PGEN Media Mentions By Week PGEN Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PGEN News Sentiment▼0.000.55▲Average Medical News Sentiment PGEN News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PGEN Articles This Week▼31▲PGEN Articles Average Week Get Precigen News Delivered to You Automatically Sign up to receive the latest news and ratings for PGEN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: NKTX News Today TERN News Today ATAI News Today URGN News Today RANI News Today NLTX News Today AVIR News Today ORGO News Today HRTX News Today FBLG News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PGEN) was last updated on 5/11/2024 by MarketBeat.com Staff From Our PartnersThe A.I. story nobody is telling you (Read ASAP)TradeSmithThe Crypto 9-5 Escape PlanCrypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeCollapse of the Petrodollar Colonial MetalsForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressHow Biden has already won 2024Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Precigen, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.